Amedisys Inc. buy Royal Bank of Canada
Start price
16.04.25
/
50%
€79.50
Target price
16.04.26
€88.29
Performance (%)
6.92%
End price
17.04.26
-
Summary
This prediction is currently being closed. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 6.92%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amedisys Inc. | - | - | - |
| iShares Core DAX® | -0.676% | 4.053% | 2.212% |
| iShares Nasdaq 100 | 0.993% | 10.872% | 38.041% |
| iShares Nikkei 225® | 3.279% | 13.468% | 59.003% |
| iShares S&P 500 | 0.621% | 6.195% | 26.154% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amedisys Inc. diskutieren
Amedisys, Inc. (NASDAQ: AMED) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Ratings data for AMED provided by MarketBeat
In the thread Trading Amedisys Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten